|
|
Article: Sigma signals 'modest' growth after $32m profit.(Financial report)
- Article from:
- Australasian Business Intelligence
- Article date:
- September 14, 2009
CopyrightCOPYRIGHT 2009 News provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Teresa Ooi
Sep 14, 2009 (The Australian - ABIX via COMTEX) -- Underlying 2009 interim net profit for Sigma Pharmaceuticals declined 5.9% to come in at $A30.2m, although the headline result was up 4.9% to $A32.2m. Elmo de Alwis, the CEO, expects an unspectacular but solid earnings increase in the full-year period. The dividend is level at $A0.03 fully-franked. Sigma is buying 15 brands from Bristol-Myers Squibb. On 14 September 2009 the stock closed $A0.01 lower at $A1.06.
Publication Date: 15 September 2009
SIGMA PHARMACEUTICALS LIMITED - ASX SIP
BRISTOL-MYERS SQUIBB PHARMACEUTICALS PTY LTD
HERRON PHARMACEUTICALS PTY LTD ...